Patient Guide: Pharmacokinetic Similarity Between ABP 234 and Keytruda® (Pembrolizumab)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • ✓ Get matched to the right study location for you
  • ✓ Connect directly with study coordinators at 128 participating sites
  • ✓ Understand eligibility with our simplified screening tool
  • ✓ Free service - we're here to help you access clinical research
Trial ID: NCTNCT06430866
Status: 🟢 Enrolling Now
Condition: Early-stage Non-squamous Non-small Cell Lung Cancer (NSCLC)
Phase: PHASE3

Find a Study Location Near You

This study is available at 128 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • • San Salvador de Jujuy, Jujuy Province
  • • Rosario, Santa Fe Province
  • • Córdoba,
  • • And 125 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Pharmacokinetic Similarity Between ABP 234 and Keytruda® (Pembrolizumab) - Join Clinical Trial NCTNCT06430866

How to Join This Clinical Trial - NCTNCT06430866

Learn how to participate in this PHASE3 trial studying an investigational therapy for Early-stage Non-squamous Non-small Cell Lung Cancer (NSCLC). This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Early-stage Non-squamous Non-small Cell Lung Cancer (NSCLC). Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Early-stage Non-squamous Non-small Cell Lung Cancer (NSCLC)
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06430866 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 128 locations. Find a study site near you:

Clinical Research Site

San Salvador de Jujuy, Jujuy Province 4600 - Argentina

Status: RECRUITING

Clinical Research Site

Rosario, Santa Fe Province S2000KZE - Argentina

Status: RECRUITING

Clinical Research Site

Córdoba, X5000HWE - Argentina

Status: RECRUITING

Clinical Research Site

Sofia, 1797 - Bulgaria

Status: RECRUITING

Clinical Research Site

Providencia, Region Metropolotana 7500859 - Chile

Status: RECRUITING

Clinical Research Site

Viña Del Mar, Región de Valparaíso 2540364 - Chile

Status: RECRUITING

Clinical Research Site

Viña del Mar, Región de Valparaíso 2520598 - Chile

Status: RECRUITING

Clinical Research Site

Providencia, Santiago Metropolitan 7500921 - Chile

Status: TERMINATED

Clinical Research Site

Region Metropolitana, Santiago Metropolitan 7560908 - Chile

Status: RECRUITING

Clinical Research Site

Santiago, Santiago Metropolitan 7520349 - Chile

Status: RECRUITING

And 118 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Early-stage Non-squamous Non-small Cell Lung Cancer (NSCLC):

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai as Your Clinical Trial Matching Service

Quri.ai is a free clinical trial matching service that helps patients connect with research sites. We make it easier to:

  • Find clinical trials that match your condition
  • Get matched to the right study location near you
  • Connect directly with study coordinators
  • Understand if you qualify with simplified eligibility screening
  • Navigate the enrollment process with personalized support
  • Access new treatments through clinical research participation